Hello, Fool! | Login | Signup | My Fool
Oct 15, 2008 10:13 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.
View All Commentary (ONXX)
Recs
Jeffreyw (36.83) Submitted: 4/25/08 11:57 AM : Start Price: $55.80 ONXX Score: -16.55
I had hoped for a better performance by now, but I'm still willing to hang on and give this one some more time. Breakthroughs don't always happen but when they do, the stock price will soar!
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK